AAAAAA

   
Results: 1-8 |
Results: 8
PROGNOSTIC VALUE OF BONE-MARROW BIOPSY IN OPERABLE BREAST-CANCER PATIENTS AT THE TIME OF INITIAL DIAGNOSIS - RESULTS OF A 20-YEAR MEDIAN FOLLOW-UP
Authors: LANDYS K PERSSON S KOVARIK J HULTBORN R HOLMBERG E
Citation: K. Landys et al., PROGNOSTIC VALUE OF BONE-MARROW BIOPSY IN OPERABLE BREAST-CANCER PATIENTS AT THE TIME OF INITIAL DIAGNOSIS - RESULTS OF A 20-YEAR MEDIAN FOLLOW-UP, Breast cancer research and treatment, 49(1), 1998, pp. 27-33
TREATMENT OF LOW-GRADE B-NHL WITH PREDNIMUSTINE IS NOT ASSOCIATED WITH AN INCREASED RISK FOR SECONDARY, NEOPLASIA
Authors: BUSKE C UNTERHALT M HERMANN R KOCH P TRUMPER L BODENSTEIN H DIETZFELBINGER H LANDYS K REUSS M VETTER H MASCHMEYER G FREUND M NEUBAUER A ENGERT A STAUDER R HEROLD M TIEMANN A PAWARESCH R STEIN H HIDDEMANN W
Citation: C. Buske et al., TREATMENT OF LOW-GRADE B-NHL WITH PREDNIMUSTINE IS NOT ASSOCIATED WITH AN INCREASED RISK FOR SECONDARY, NEOPLASIA, Blood, 90(10), 1997, pp. 1535-1535
PROGNOSTIC DETERMINANTS FOR LONG-TERM OUTCOME OF LOW-GRADE FOLLICULARLYMPHOMAS AFTER CYTOREDUCTIVE CHEMOTHERAPY AND INTERFERON-ALPHA MAINTENANCE - RESULTS OF THE GERMAN LOW-GRADE LYMPHOMA STUDY-GROUP (GLSG)
Authors: UNTERHALT M HERMANN R KOCH P TRUMPER L BODENSTEIN H DIETZFELBINGER H LANDYS K REUSS M VETTER H MASCHMEYER G FREUND M NEUBAUER A ENGERT A STAUDER R HEROLD M TIEMANN M PARWARESCH R STEIN H HIDDEMANN W
Citation: M. Unterhalt et al., PROGNOSTIC DETERMINANTS FOR LONG-TERM OUTCOME OF LOW-GRADE FOLLICULARLYMPHOMAS AFTER CYTOREDUCTIVE CHEMOTHERAPY AND INTERFERON-ALPHA MAINTENANCE - RESULTS OF THE GERMAN LOW-GRADE LYMPHOMA STUDY-GROUP (GLSG), Blood, 90(10), 1997, pp. 1743-1743
PREDNIMUSTINE, MITOXANTRONE (PMM) VS CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE (COP) FOR THE TREATMENT OF ADVANCED LOW-GRADE NON-HODGKINS-LYMPHOMA
Authors: UNTERHALT M HERRMANN R TIEMANN M PARWARESCH R STEIN H TRUMPER L NAHLER M REUSSBORST M TIRIER C NEUBAUER A FREUND M KREUSER ED DIETZFELBINGER H BODENSTEIN H ENGERT A STAUDER R EIMERMACHER H LANDYS K HIDDEMANN W
Citation: M. Unterhalt et al., PREDNIMUSTINE, MITOXANTRONE (PMM) VS CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE (COP) FOR THE TREATMENT OF ADVANCED LOW-GRADE NON-HODGKINS-LYMPHOMA, Leukemia, 10(5), 1996, pp. 836-843
LONG-TERM INTERFERON-ALPHA MAINTENANCE PROLONGS REMISSION DURATION INADVANCED LOW-GRADE LYMPHOMAS AND IS RELATED TO THE EFFICACY OF INITIAL CYTOREDUCTIVE CHEMOTHERAPY
Authors: UNTERHALT M HERMANN R KOCH P TRUMPER L BODENSTEIN H DIETZFELBINGER H LANDYS K REUSS M VETTER H MASCHMEYER G FREUND M NEUBAUER A ENGERT A STAUDER R HEROLD M TIEMANN M PARWARESCH R STEIN H HIDDEMANN W
Citation: M. Unterhalt et al., LONG-TERM INTERFERON-ALPHA MAINTENANCE PROLONGS REMISSION DURATION INADVANCED LOW-GRADE LYMPHOMAS AND IS RELATED TO THE EFFICACY OF INITIAL CYTOREDUCTIVE CHEMOTHERAPY, Blood, 88(10), 1996, pp. 1801-1801
PROGNOSTIC VALUE OF BONE-MARROW BIOPSY IN OPERABLE BREAST-CANCER PATIENTS AT THE TIME OF INITIAL DIAGNOSIS - RESULTS OF A 19-YEAR MEDIAN FOLLOW-UP
Authors: LANDYS K PERSSON S KOVARIK J HULTBORN R HOLMBERG E
Citation: K. Landys et al., PROGNOSTIC VALUE OF BONE-MARROW BIOPSY IN OPERABLE BREAST-CANCER PATIENTS AT THE TIME OF INITIAL DIAGNOSIS - RESULTS OF A 19-YEAR MEDIAN FOLLOW-UP, European journal of cancer, 31A, 1995, pp. 647-647
SIGNIFICANT PROLONGATION OF DISEASE-FREE SURVIVAL IN ADVANCED LOW-GRADE NON-HODGKIN LYMPHOMAS (NHL) BY INTERFERON-ALPHA MAINTENANCE
Authors: UNTERHALT M HERRMANN R NAHLER M TRUMPER L BODENSTEIN H LANDYS K REUSS M VETTER H MASCHMEYER G FREUND M NEUBAUER A ENGERT A STAUDER R TIEMANN M PARWARESCH R STEIN H HIDDEMANN W
Citation: M. Unterhalt et al., SIGNIFICANT PROLONGATION OF DISEASE-FREE SURVIVAL IN ADVANCED LOW-GRADE NON-HODGKIN LYMPHOMAS (NHL) BY INTERFERON-ALPHA MAINTENANCE, Blood, 86(10), 1995, pp. 1744-1744
INTRALESIONAL ADMINISTRATION OF BLEOMYCIN (ILB) FOR ORAL KAPOSIS-SARCOMA IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS)
Authors: LANDYS K HASSEUS B RODSTROM PO HAKANSSON C LOWHAGEN GB BERGBRANT IM
Citation: K. Landys et al., INTRALESIONAL ADMINISTRATION OF BLEOMYCIN (ILB) FOR ORAL KAPOSIS-SARCOMA IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS), Lymphology, 27, 1994, pp. 768-771
Risultati: 1-8 |